Ganesha Ecosphere
- Market cap
- ₹ 2,642 Cr.
- P/E
- 48.9x
- P/B
- 2.02x
- 52-week range
- 653.55 – 1,268
- ROE
- 3%
- ROCE
- 5%
- Dividend yield
- 0.4%
- Debt / equity
- 0.39
- Sector
- Textiles & Apparels
- Industry
- Other Textile Products
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Textile Products: 275 companies →Ganesha Ecosphere against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)48.9 against a typical 16.6: pricier than most peers (1st = cheapest).204th of 268
- Sales growth+25.8% against a typical +6.7% from a year earlier.58th of 234
- Profit growth+163.6% against a typical +12.9% from a year earlier.27th of 166
- Share price, 3 months−14.6% against a typical −4%.171st of 240
- Size₹ 2,641.6 Cr. market value against a typical ₹ 58.7 Cr. (1st = largest).13th of 256
Latest announcements
Exchange filings and their impact on the company.
- 16 Oct 2026Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvalsMedium impactPositivePrice −2.9% on 19 OctFSSAI cleared food-grade rPET production from its fourth Warangal line, unlocking premium volumes for two years.
Ganesha Ecosphere said its wholly-owned subsidiary Ganesha Ecopet received FSSAI approval on October 15, 2026 for its fourth rPET production line at Kakatiya Mega Textile Park, Warangal, Telangana. The approval authorizes manufacture of food-grade rPET for food contact use with Starlinger recoSTAR PET technology and is valid for two years to October 14, 2028. This clears the new line to produce and sell higher-value food-grade recycled PET over the next year.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A+ by CARE- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE A+ | Stable | 6 Jan 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Jan 2026 | Reaffirmed | CARE A+ | — | CARE | ₹ 210 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 31 Oct 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 3 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 21 May 2026 | Financial Results/Dividend | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended March 31, 2026 and To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 7 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 10 Nov 2025 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company for the Quarter and half year ended September 30, 2025. |
| 13 Aug 2025 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company for the Quarter ended June 30, 2025. |
| 24 May 2025 | Financial Results/Dividend | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended March 31, 2025. and To consider recommendation of Final Dividend, if any, for the financial year 2024-25. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 278 | 285 | 306 | 337 | 387 | 398 | 344 | 337 | 363 | 357 | 424 | 424 |
| Expenses | 253 | 245 | 258 | 289 | 332 | 341 | 293 | 301 | 341 | 326 | 372 | 364 |
| Operating Profit | 25 | 40 | 47 | 48 | 55 | 57 | 51 | 36 | 22 | 31 | 52 | 60 |
| OPM % | 9% | 14% | 15% | 14% | 14% | 14% | 15% | 11% | 6% | 9% | 12% | 14% |
| Other Income | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 3 | 5 | 4 | 5 | 4 |
| Interest | 12 | 13 | 9 | 8 | 10 | 11 | 10 | 10 | 11 | 10 | 9 | 9 |
| Depreciation | 12 | 12 | 12 | 13 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 17 |
| Profit before tax | 4 | 19 | 31 | 30 | 36 | 37 | 32 | 14 | 1 | 8 | 31 | 37 |
| Tax % | 38% | 33% | 29% | 25% | 25% | 20% | 27% | 25% | 186% | 42% | 25% | 22% |
| Net Profit | 3 | 13 | 22 | 23 | 27 | 30 | 24 | 11 | 0 | 5 | 23 | 29 |
| EPS in Rs | 1.28 | 5.83 | 8.52 | 8.9 | 10.7 | 11.72 | 9.33 | 4.22 | −0.19 | 1.77 | 8.66 | 10.83 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 15%
- 3 Years
- 8%
- TTM
- 7%
- 10 Years
- —
- 5 Years
- −2%
- 3 Years
- −18%
- TTM
- −38%
- 10 Years
- 18%
- 5 Years
- 16%
- 3 Years
- 0%
- TTM
- —
- 10 Years
- —
- 5 Years
- 7%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.